André-Michel Ballester

André-Michel Ballester

Private Equity Investor at
ArchiMed SAS
68 year
Health Technology
Consumer Services
Process Industries

Profile

Mr. André-Michel Ballester is a Managing Partner at ArchiMed SAS and a Managing Partner at North American Science Associates LLC.
Mr. Ballester was previously employed as a Lead Independent Director by DiaSorin SpA, a Chief Executive Officer & Director by LivaNova Plc, an Independent Director by Pixium Vision SA, an Independent Director by Mauna Kea Technologies SA, an Independent Director by Carmat SA, a Chief Executive Officer & Director by Sorin SpA, a Vice President-Europe, Middle East & Africa Region by Edwards Lifesciences Corp., a President-CardioVascular Group by Baxter Cardiovascular Group, a Chairman by Bomi Italia SpA, and a Chairman by Suan Farma SA. He also served on the board at IMI Intelligent Medical Implants AG and Natus Medical, Inc. He received his undergraduate degree from École centrale de Lille and an MBA from INSEAD.

André-Michel Ballester active positions

CompaniesPositionStart
Private Equity Investor 31/12/2017
Corporate Officer/Principal 23/02/2025

Former positions of André-Michel Ballester

CompaniesPositionEnd
LIVANOVA PLC Chief Executive Officer 30/12/2016
MAUNA KEA TECHNOLOGIES Director/Board Member 16/12/2015
SORIN SPA Chief Executive Officer 30/09/2015
EDWARDS LIFESCIENCES CORPORATION Corporate Officer/Principal -
Chairman -
See the detail of André-Michel Ballester's experience

Training of André-Michel Ballester

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Process Industries

Health Technology

Consumer Services

Distribution Services

Commercial Services

Health Technology

Transportation

Baxter Cardiovascular Group

Health Technology

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. André-Michel Ballester